A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)

NCT07500207 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

3000

Enrollment

INDUSTRY

Sponsor class

Conditions

Rabies Prevention

Interventions

BIOLOGICAL: Experimental Lyophilized Human Rabies Vaccine (Human Diploid Cell)
BIOLOGICAL: approved Rabies vaccine

Sponsor

Changchun BCHT Biotechnology Co.